According to the report, the United States had the highest prices for all four drugs, with costs ranging from $936 (Ozempic/Rybelsus) to $1,349 (Wegovy) for a one-month supply.
For Ozempic, a one-month supply in the United States ($936) is over five times higher than the cost in Japan ($169), the second highest price point for the drug. The lowest price point for Ozempic is $83 in France.
Rybelsus has the same price point as Ozempic ($936) in the United States, which is over four times greater than the second highest price point of $203 in the Netherlands. Wegovy and Mounjaro are also priced between two and three times higher in the United States than in other countries that offer the drug.